Latest Lead News

GemLife has secured a $21 million greenfield site in Townsville, Queensland, aiming to develop over 500 new homes and boost its Land Lease Community portfolio.

Felix Gold Limited reports strong continuity of high-grade antimony mineralisation at its NW Array prospect in Alaska, while engaging Worley to accelerate processing pathways. The company targets near-term bulk sampling and production aligned with US strategic supply needs.

Bapcor Limited has appointed Chris Wilesmith as its new CEO and Managing Director, signaling a strategic leadership shift aimed at accelerating growth in the automotive aftermarket sector.

IDP Education has updated its revenue recognition policy to recognise Student Placement revenue at census date across all jurisdictions, leading to restated FY25 financials and reaffirmed FY26 guidance.

OMG Group has achieved over $3 million in sales for the first half of FY2026, marking its strongest half-year performance since new management took charge. The company is poised for further growth with upcoming marketing campaigns and retail partnerships.

TrivarX Limited has reported compelling clinical trial results demonstrating its single-lead ECG algorithm’s high sensitivity in detecting major depressive episodes among US veterans, marking a significant step in objective mental health screening.

Bailador Technology Investments has increased the valuations of its portfolio companies Updoc and PropHero, driving a notable uplift in net tangible assets per share and signaling strong early performance in FY26.

Dexus reports a modest $83 million uplift in portfolio valuation driven by rental growth, alongside an estimated 19.3 cents per security distribution for H2 2025.

DEXUS has announced an estimated ordinary distribution of AUD 0.193 per unit for the six months ending December 2025, marking a steady income stream for investors ahead of the new year.

Truscott Mining Corporation has initiated a $1.44 million capital raise through a share placement accompanied by unlisted options, aiming to bolster its exploration and development efforts.

Neurotech International has locked in $4 million through a share placement to advance its promising paediatric neurological drug, NTI164. The raise, supported by both new and existing investors including company directors, aims to fund critical clinical and regulatory milestones.

Variscan Mines has secured government approval for its Preliminary Mining Plan, enabling critical pre-works and trial mining at the San Jose Mine in Spain. This milestone accelerates the company’s strategy to restart production with minimal capital expenditure.